Patents by Inventor Brian TILL

Brian TILL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for CD20 immunotherapy
    Patent number: 11834511
    Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: December 5, 2023
    Assignee: Fred Hutchinson Cancer Center
    Inventors: Oliver Press, Brian Till
  • COMPOSITIONS AND METHODS FOR CD20 IMMUNOTHERAPY
    Publication number: 20210147569
    Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.
    Type: Application
    Filed: November 24, 2020
    Publication date: May 20, 2021
    Inventors: Oliver PRESS, Brian TILL
  • Compositions and methods for CD20 immunotherapy
    Patent number: 10875927
    Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: December 29, 2020
    Assignee: FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: Oliver Press, Brian Till
  • COMPOSITIONS AND METHODS FOR CD20 IMMUNOTHERAPY
    Publication number: 20190106501
    Abstract: The present disclosure provides compositions and uses thereof for treating a disease or disorder associated with CD20 expression. Treatments of this disclosure include use of a host cell expressing a fusion protein, such as an anti-CD20 CAR, optionally in combination with a CD20-specific binding molecule, a chemotherapeutic, an inhibitor of an immunosuppression component, or combinations thereof.
    Type: Application
    Filed: March 17, 2017
    Publication date: April 11, 2019
    Inventors: Oliver PRESS, Brian TILL
  • Fe(o)-based bioremediation of aquifers contaminated with mixed wastes
    Patent number: 6719902
    Abstract: Disclosed are methods, devices and apparatus for bioremediation of mixed waste aquifers, based on a synergistic combination of reductive treatment using zero-valent iron and anaerobic biotransformations. Also disclosed are methods for in situ and ex situ remediation of groundwater and wastewater via these iron-bacterial compositions in a variety of devices including batch reactors, permeable and semipermeable reactive barriers, flow-through reactors, fluidized bed reactors, and sediment tanks.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: April 13, 2004
    Assignee: The University of Iowa Research Foundation
    Inventors: Pedro J. Alvarez, Brian A. Till, Lenly J Weathers, Gene F. Parkin, Jerald L. Schnoor